Collaborative Projects on Proteomics/Metabolomics and Type 1 Diabetes and its Complications
To encourage the application of proteomic and metabolomic technologies to study type 1 diabetes and its complications, the NIDDK is fostering collaborations between type 1 diabetes researchers and investigators with expertise in proteomics and/or metabolomics.
More Information
Return to Research Consortia and Clinical Trials Networks Topic List